By THE ASSOCIATED PRESSSEPT. 19, 2016
Stocks on Wall Street wobbled and finished mostly lower Monday as investors waited for central bank meetings in the United States and Japan. Health care and technology companies took some of the biggest losses, while banks rose.Investors were indecisive as leaders of the Federal Reserve and Bank of Japan prepared to meet, and stocks swung several times between gains and losses. The Dow rose as much as 131 points early on, then fell as much as 30 points in the afternoon. Banks, utility companies and machinery makers rose. Bond yields edged higher and the dollar weakened.While advancing stocks far outnumbered decliners, the Dow Jones industrial average dipped 3.63 points, or less than 0.1 percent, to 18,120.17. The Standard & Poor’s 500 index lost 0.04 points to 2,139.12. The Nasdaq composite fell 9.54 points, or 0.2 percent, to 5,235.03.The Federal Reserve will meet on Tuesday and announce its latest decision on interest rates on Wednesday. Bank stocks were among the gainers as some investors hoped that interest rates would rise, which would allow banks to make more money from lending. JPMorgan Chase rose 37 cents to $66.19 and Wells Fargo regained 58 cents, or 1.3 percent, to $46.01.
            Position of the Dow Jones industrial average at 1-minute intervals on Monday.        18,26018,20018,140Previous close18,123.8018,08010 a.m.Noon2 p.m.4 p.m.SEPT. 19, 2016
The technology products distributor Tech Data jumped after it said it would buy the technology solutions business of Avnet for $2.6 billion in cash and stock. Tech Data says the deal will give it operations in 35 countries. Its stock rose $15.46, or 22.3 percent, to $84.80 and Avnet gained $2.68, or 6.8 percent, to $41.89.AdvertisementAt the same time, the network control company Infoblox agreed to be bought by Vista Equity Partners for $26.50 a share, or $1.51 billion. It surged $3.52, or 15.4 percent, to $26.35.AdvertisementDespite those gains, the broader technology sector gave up an early advance and finished mostly lower. Apple, which surged last week and reached its highest price this year, lost $1.34, or 1.2 percent, to $113.58 and Intel fell 51 cents, or 1.4 percent, to $37.16.Sarepta Therapeutics soared $20.79, or 73.9 percent, to $48.94 after the Food and Drug Administration granted tentative approval to its drug Exondys 51, a treatment for a type of muscular dystrophy.The health website operator WebMD slumped after it said its chief executive, David Schlanger, was leaving the company by mutual agreement. Mr. Schlanger is being replaced by the president, Steven Zatz, who is in charge of WebMD’s advertising and sponsorship business. WebMD fell $2.95, or 5.7 percent, to $49.02. It is down 27 percent since May 25.
            High rate at weekly auction.        0.40%0.360.320.280.305%0.20 June July Aug.SEPT. 19, 2016
General Motors gained 75 cents, or 2.4 percent, to $31.72 after an analyst said auto sales, which are at record highs, should remain strong for several years. Adam Jonas, an analyst at Morgan Stanley, raised his rating on G.M. to overweight and raised his price target to $37 a share from $29.Benchmark crude added 27 cents, to $43.30 a barrel in New York. Brent crude, used to price international oils, rose 18 cents, to $45.95 a barrel in London.Gold rose $7.37, to $1,313.17 an ounce. Silver added 43 cents, or 2.3 percent, to $19.29 an ounce. Copper remained at $2.16 a pound.Government bond prices slipped. The yield on the 10-year Treasury note rose to 1.71 percent from 1.69 percent. The dollar fell to 101.81 yen from 102.42 yen. The euro rose to $1.1177 from $1.1151.The FTSE 100 index of leading British shares climbed 1.5 percent and the CAC-40 in France rose 1.4 percent. In Germany, the DAX was 1 percent higher. The South Korean Kospi added 0.8 percent and Hong Kong’s Hang Seng index rose 0.9 percent. Trading in Japan was closed for a holiday.A version of this article appears in print on September 20, 2016, on Page B4 of the New York edition with the headline: Wall St. Teeters as Investors Await Fed’s Decision.  Order Reprints| Today's Paper|Subscribe

We’re interested in your feedback on this page. Tell us what you think.